[Docetaxel-based combination chemotherapy for castration-resistant prostate cancer].
Department of Urology, The Cancer Institute Hospital of the Japanese Foundation for Cancer Research (JFCR).
Shinji
S
Urakami
Hiroaki
H
Shiina
Mikio
M
Igawa
D000970:Antineoplastic Agents / Q000008:administration & dosage*; D000971:Antineoplastic Combined Chemotherapy Protocols; D002369:Castration; D000077143:Docetaxel; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D043823:Taxoids / Q000008:administration & dosage*
D000970:Antineoplastic Agents; D043823:Taxoids; D000077143:Docetaxel